Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01080521 · ClinicalTrials.gov registry record

Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy

A clinical trial, sponsored by Gynecologic Oncology Group.

Completed
Registry status
247
Enrollment target

NCT01080521: Completed study, sponsored by Gynecologic Oncology Group.

NCT01080521 is a clinical trial that has completed, run by Gynecologic Oncology Group. The registered enrollment target is 247 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01080521 has completed, sponsored by Gynecologic Oncology Group.

COMPLETED
Registry status
247 participants
Enrollment target

Study Summary

This clinical trial is studying changes in brain function in patients with stage I, stage II, stage III, or stage IV ovarian, primary peritoneal, or fallopian tube cancer who are receiving chemotherapy. Learning about the effects of chemotherapy on brain function may help doctors plan cancer treatments.

Interventions

  • OTHER Quality-of-Life Assessment
  • PROCEDURE Cognitive Assessment

Trial Details

FieldValue
Enrollment Target 247 participants
Start Date 2010-04
Est. Completion 2018-01-27
Gynecologic Oncology Group

154 total trials

What the finished NCT01080521 record still lists

NCT01080521 is an observational study that tracks outcomes without assigning an intervention. The registered 247 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 2 interventions - of which Quality-of-Life Assessment is the first listed.

NCT01080521 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01080521 about?

NCT01080521 is a clinical study titled "Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy". This clinical trial is studying changes in brain function in patients with stage I, stage II, stage III, or stage IV ovarian, primary peritoneal, or fallopian tube cancer who are receiving chemotherapy. Learning about the effects of chemotherapy on brain function may help doctors plan cancer treatme...

What is the current status of trial NCT01080521?

This trial is currently completed. The enrollment target is 247 participants. The study started on 2010-04. Estimated completion is 2018-01-27.

What interventions are being tested in trial NCT01080521?

The interventions under investigation include: Quality-of-Life Assessment (OTHER), Cognitive Assessment (PROCEDURE).

Who is sponsoring clinical trial NCT01080521?

This trial is sponsored by Gynecologic Oncology Group, which has 154 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04269902 · 247 participants · Phase 3

    Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

  • NCT04989803 · 247 participants · Phase 1

    Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma

  • NCT05521399 · 247 participants

    Heart Transplantation - Renewal

  • NCT05556824 · 247 participants · Phase 2

    Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01080521, the US trial registry maintained by the National Library of Medicine. NCT01080521 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.